According to Revolution Medicines
's latest financial reports the company has HK$16.50 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | HK$17.77 B | 22.81% |
2023-12-31 | HK$14.47 B | 187.19% |
2022-12-31 | HK$5.03 B | 11.99% |
2021-12-31 | HK$4.49 B | 31.69% |
2020-12-31 | HK$3.41 B | 257.38% |
2019-12-31 | HK$0.95 B | 75.45% |
2018-12-31 | HK$0.54 B | 668.21% |
2017-12-31 | HK$70.93 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | HK$1.59 B | -90.31% | ๐บ๐ธ USA |